NLG(13)398. DATE 29 October Trust Board of Directors Part A. Wendy Booth, Director of Clinical and Quality Assurance & Trust Secretary

Similar documents
NLG(15)329. DATE 28 July Trust Board of Directors Public REPORT FOR. Kathryn Helley, Deputy Director of Performance Assurance & Trust Secretary

GROUP GOVERNANCE FRAMEWORK MANUAL

UNIVERSITY COLLEGE LONDON HOSPITALS NHS FOUNDATION TRUST AUDIT COMMITTEE ANNUAL REPORT 2011/2012

ROYAL AUSTRALASIAN COLLEGE OF SURGEONS Division Resources Ref. No. RES-MGT-007

NHS SOUTH LINCOLNSHIRE CLINICAL COMMISSIONING GROUP AUDIT & RISK COMMITTEE TERMS OF REFERENCE

NHS Darlington Clinical Commissioning Group Audit and Risk Committee Terms of Reference

Integrated Risk Management Framework Sept Page 1 of 17

Discussion. Information

Transactions guidance for trusts undertaking transactions, including mergers and acquisitions

Audit Committees in Common. NHS Leeds North CCG, NHS Leeds South and East CCG and NHS Leeds West CCG. Terms of Reference

Audit Committee: Terms of Reference

Risk Management Strategy

Regulatory Notice 4: Regulation of newly registered providers up to 31 July 2019

Finance, Performance and Strategic Planning Committee Terms of Reference

Risk Management Procedure. Version Number: 6.0 Controlled Document Sponsor: Controlled Document Lead:

Risk Assessment and Risk Register

SHAW COMMUNICATIONS INC. AUDIT COMMITTEE CHARTER

The Annual Audit Letter for Royal National Orthopaedic Hospital NHS Trust

The Audit Findings for University Hospitals of Morecambe Bay NHS Foundation Trust

Declaring and Managing Interests Including Managing Conflicts of Interest

The Annual Audit Letter for West Hertfordshire Hospitals NHS Trust

Audit Committee Annual Report to the Board

AUDIT AND FINANCE COMMITTEE TERMS OF REFERENCE

Introduction. Regulation Number and Paragraph. Citation, commencement, interpretation and application

BOARD OF DIRECTORS PAPER COVER SHEET. Meeting Date: 27 July 2011

Legal Advice and Services Policy CONTROLLED DOCUMENT

BOARD OF DIRECTORS OF IPB INSURANCE

Market Oversight. Draft guidance for providers

Risk Management Policy and Strategy

AUDIT & RISK COMMITTEE CHARTER

DIRECTIVE ON OPERATIONS PROCUREMENT A. OVERRIDING OBJECTIVE B. DEFINITIONS

Policies, Procedures, Guidelines and Protocols

APN Funds Management Limited Board Charter August 2017

MS10 Regulatory Minimum Standards

Queen s University Belfast. Risk Management. Policy and Procedures

Trust Board Meeting in Public: Wednesday 9 May 2018 TB This is a regular report to the Board

Leeds Building Society Audit Committee Terms of Reference

BOARD OF DIRECTORS COVER SHEET. Meeting Date: 25 July 2012

Health Committee. From Dr Sarah Wollaston MP, Chair. The Rt Hon Jeremy Hunt MP Secretary of State for Health Department of Health. Letter by to

Audit and Financial Risk Committee Charter

Air Partner plc (the Company ) Terms of reference for the Audit and Risk Committee (the Committee )

WHISTLEBLOWER POLICY

University of Greenwich Risk Management Guide Revised October 2017

Risk management procedures

NLG(15)333. DATE OF MEETING 28 July Trust Board of Directors Public REPORT FOR

Risk Management Policy

6. Terms of Reference Local Governing Body

ensure there is an effective internal audit function established by management, which provides appropriate independent assurance to the Committee;

SOMERSET PARTNERSHIP NHS FOUNDATION TRUST RISK MANAGEMENT POLICY. Report to the Trust Board 26 May Risk and Compliance Manager

South Lanarkshire College Risk Management Policy and Procedures

Québec Reliability Standards Compliance Monitoring and Enforcement Program (QCMEP) October 10, Effective date: To be set by the Régie

Operational Performance. SaTH Overall Performance

ESMA-EBA Principles for Benchmark-Setting Processes in the EU

CODE OF CONDUCT FOR THE IBA PRECIOUS METALS AUCTIONS AND THE LBMA GOLD AND SILVER PRICE BENCHMARKS

NLG(18)407. DATE OF MEETING 27 November Trust Board of Directors Public. Wendy Booth, Trust Secretary

CENTRAL MANCHESTER UNIVERSITY HOSPITALS NHS FOUNDATION TRUST

GOVERNING BODY REPORT

Terms of Reference of the Audit Committee. 2.1 The Committee shall consist of a Chairman and not fewer than two other members.

RISK REGISTER POLICY AND PROCEDURE

South Lincolnshire NHS Clinical Commissioning Group Business Continuity Policy

PAYMENT SYSTEMS OVERSIGHT UNIT OPERATIONAL FRAMEWORK

Integrated Quality, Performance and Finance Reporting Framework. Reporting period: Month 9 December 2014

Documentation Control. Hazard Identification, Risk Assessment and Management Procedure. (This document is linked GG/CM/007- Risk Management Policy)

The Annual Audit Letter for NHS Croydon Clinical Commissioning Group

IOPS/OECD MENA Workshop- February 2 nd 2009

CoG (07/16) Item 6.2. Council of Governors. Dr Jim Whittingham. Dr Jim Whittingham. Board Highlights Report N/A

PRIME FINANCIAL POLICIES

NHS Newcastle Gateshead Clinical Commissioning Group Audit Committee Terms of Reference

Risk Management. Policy and Procedures

Principal risks and uncertainties

TURKS & CAICOS ISLANDS FINANCIAL SERVICES COMMISSION COMPLIANCE REPORT (TEMPLATE)

2.2 For Board Members to approve the five high risks the Trust is facing:

FINAL NOTICE. Toronto Dominion Bank (London Branch)

AUDIT COMMITTEE. Terms of Reference

The Annual Audit Letter for Chorley and South Ribble Clinical Commissioning Group

RISK MANAGEMENT FRAMEWORK

The Annual Audit Letter for Torbay and Southern Devon Health and Care NHS Trust

SSC Inquiry into the Use of External Security Consultants by Government Agencies

Risk Management Policy

Board Risk & Compliance Committee Charter

Medical Professional Liability Insurance for AfPP Members

RISK MANAGEMENT FRAMEWORK

Dispute Resolution Policy:

Library Director Performance Appraisal. Director: Date:

Risk. Protocol for the Management of Risk

Anti - Fraud and Corruption Policy

Corporate Governance Requirements for Investment Firms and Market Operators 2018

BOARD ASSURANCE FRAMEWORK & SIGNIFICANT RISK REGISTER Trust Board in public

BOLSAS Y MERCADOS ESPAÑOLES, SISTEMAS DE NEGOCIACIÓN, S.A. ALTERNATIVE EQUITY MARKET GENERAL REGULATIONS

Risk Management Framework

RISK MANAGEMENT FRAMEWORK OVERVIEW

Risk management policy

Manchester Health and Care Commissioning. Finance Committee. Terms of Reference

Procedure for the Development of Policies

Risk Management Strategy January NHS Education for Scotland RISK MANAGEMENT STRATEGY

Supplement No.18 published with Gazette No.15 dated 28 July, THE SECURITIES INVESTMENT BUSINESS LAW (2003 REVISION)

George Eliot Hospital NHS Trust - Securing a sustainable future Project. Annex A

SOMERSET PARTNERSHIP NHS FOUNDATION TRUST SECURITY MANAGEMENT ANNUAL REPORT Report to the Trust Board 28 June 2016

Consultation Paper. Principles for Benchmarks-Setting Processes in the EU. 11 January 2013 ESMA/2013/12

Annual Audit Letter Year ending 31 March NHS Shropshire CCG 27 June 2018

Transcription:

DATE 29 October 2013 REPORT FOR Trust Board of Directors Part A REPORT FROM Wendy Booth, Director of Clinical and Quality Assurance & Trust Secretary CONTACT OFFICER Kathryn Helley, Deputy Director of Clinical and Quality Assurance & Assistant Trust Secretary SUBJECT Summary of Monitor Risk Assessment Framework BACKGROUND DOCUMENT (IF ANY) Monitor Risk Assessment Framework REPORT PREVIOUSLY CONSIDERED BY & DATE(S) EXECUTIVE COMMENT (INCLUDING KEY ISSUES OF NOTE OR, WHERE RELEVANT, CONCERN AND / OR NED CHALLENGE THAT THE BOARD NEED TO BE MADE AWARE OF) The report provides a brief summary of the Monitor Risk Assessment Framework specifically in relation to governance HAVE THE STAFF SIDE BEEN CONSULTED ON THE PROPOSALS? HAVE THE RELEVANT SERVICE USERS/CARERS BEEN CONSULTED ON THE PROPOSALS? ARE THERE ANY FINANCIAL CONSEQUENCES ARISING FROM THE RECOMMENDATIONS? NO IF YES, HAVE THESE BEEN AGREED WITH THE RELEVANT BUDGET HOLDER AND DIRECTOR OF FINANCE, AND HAVE ANY FUNDING ISSUES BEEN RESOLVED? ARE THERE ANY LEGAL IMPLICATIONS ARISING FROM THIS PAPER THAT THE BOARD NEED TO BE MADE AWARE OF? NO WHERE RELEVANT, HAS PROPER CONSIDERATION BEEN GIVEN TO THE NHS CONSTITUTION IN ANY DECISIONS OR ACTIONS PROPOSED? YES ACTION REQUIRED BY THE BOARD The Board is asked to note the report

Monitor Risk Assessment Framework The new approach to overseeing NHS Foundation Trusts compliance with the governance and continuity of services requirements of their provider licence. From 1 October 2013, it replaces the Compliance Framework. Governance Implications Monitoring and Data Collection Monitor considers that foundation trusts should carry out periodic reviews of their governance. As part of the assurance they require regarding the governance of NHS foundation trusts, they expect that trusts should report the findings of external reviews covering areas of governance to help inform their assessment. They will separately publish guidance on this later on 2013. Corporate Governance Statement To comply with the governance conditions of their licence, NHS foundation trusts are required to provide a statement (the corporate governance statement) setting out: any risks to compliance with the governance condition; and actions taken or being taken to maintain future compliance. This statement replaces the board statements that NHS foundation trusts were previously required to submit with their annual plans under the Compliance Framework. Where facts come to light that could call into question information in the corporate governance statement, or indicate that an NHS foundation trust may not have carried out planned actions, Monitor is likely to seek additional information from the NHS foundation trust to understand the underlying situation. Depending on the trust s response, Monitor may decide to investigate further to establish whether there is a material governance concern that merits further action. Governor and Membership Reporting NHS foundation trusts should maintain a representative membership base. Monitor will require information from trusts on members and membership elections. Requirements for annual submission: commentary on governor development activity in previous year and plans for coming 12 months; membership data including present and projected membership by constituency, election turnout rates and stratified comparisons with eligible groups; commentary on membership strategy. Additional In year Submissions Required from Foundation Trusts Care Quality Commission Judgements: Monitor will monitor NHS foundation trusts compliance with the minimum standards of quality and safety as defined by the CQC. Where CQC warning notices, fines or other formal notices raise concerns about quality at an NHS foundation trust, Monitor will consider whether these could indicate underlying governance issues. Organisational Quality Indicators: Monitor have identified a number of indicators that may represent a risk to the current or future quality of care provided by an NHS foundation trust, including results from patient and staff surveys, staff turnover and agency staff numbers. Directorate of Clinical & Quality Assurance, October 2013 Page 2/5

Failing to identify, address or mitigate concerns raised by these indicators of organisational quality may represent poor governance. Exception Reports Examples of exception reports which will be required: third party investigations that could suggest material issues with governance, eg, fraud, CQC concerns, medical Royal Colleges reports; CQC responsive or planned reviews and their outcomes/findings; other patient safety issues which may impact compliance with the licence (eg, serious incidents); enforcement notices or other sanctions from other bodies implying potential or actual significant breach of a licence condition, eg, Office of Fair Trading; patient group concerns; concerns from whistleblowers or complaints. NHS Foundation Trusts: Independent Governance Assurance and Regular Reviews The Code of Governance for NHS Foundation Trusts requires trusts to: ensure that adequate systems and processes are maintained to measure and monitor trust s effectiveness, efficiency and economy as well as the quality of its health care delivery. The board should regularly review the performance of the NHS foundation trust in these areas against regulatory and contractual obligations and approved plans and objectives; and conduct, at least annually, a review of the effectiveness of the trust s system of internal control and report to members that they have done so. The review should cover all material controls, including financial, clinical, operational and compliance controls and risk management systems. Monitor builds on these provisions by requiring NHS foundation trusts to commission a rigorous external review of governance at least once every three years. They consider that such a review should cover at least one of the following areas of governance: board governance and leadership, including information the board receives, planning processes and how it holds management to account; the effectiveness of organisational oversight, including risk assurance processes, performance management systems, internal controls and escalation processes; quality governance, assessed against Monitors Quality Governance Framework; and the board s capability, including its composition and the effectiveness of sub committees. To support a minimum standard of assurance for these reviews, Monitor will: publish guidance, including setting a proposed scope for these reviews, and the areas for inspection. The score will mirror areas currently covered in the application process and hence laid out in the Guide for Applicants; and provide guidance in the form of indicative selection criteria that could be used by trusts in line with their procurement policies. Monitor will publish this guidance in late 2013/early 2014. Monitor sees these as primarily an opportunity to develop the sector s processes for building governance assurance. Provided the reviews that NHS foundation trusts commission cover at least the scope set out in the guidance, trusts are free to set the overall scope of the reviews they carry out. Directorate of Clinical & Quality Assurance, October 2013 Page 3/5

Trusts should report the findings of the review to Monitor. Where they raise issues of concern that might reflect on compliance with its governance condition, Monitor will consider whether to investigate further. The Governance Rating Monitor will primarily use a governance rating, incorporating information across a number of areas, to describe their views of the governance of an NHS foundation trust. We will generate this rating by considering the following information regarding the trust and whether it is indicative of a potential breach of the governance condition: performance against selected national access and outcomes standards; CQC judgements on the quality of care provided; relevant information from third parties; a selection of information chosen to reflect quality governance at the organisation; the degree of risk to continuity of services and other aspects of risk relating to financial governance; and any other relevant information. Monitor will use the information gathered under the categories outlined above (alongside other relevant information) to assess the strength of governance at an NHS foundation trust. Information that comes to light from other areas of our governance oversight may lead to overrides in the governance rating. Assigning Ratings to NHS Foundation Trusts The governance rating assigned to an NHS foundation trust reflects Monitor s views of its governance: a green rating is assigned if no governance concern is evident; where potential material causes for concern with the trust s governance are identified in one or more of the categories (requiring further information or formal investigation), Monitor will replace the Trust s green rating with a description of the issue and the steps (formal or informal) they are taking to address it; or a red rating will be assigned if regulatory action is taken. In assigning an appropriate governance risk rating, Monitor will be informed by the: seriousness of the issue; information we already have concerning the situation; effectiveness of the trust s initial response to it; and time critical nature of the situation. Monitor may require additional information from the Trust. Depending on Monitor s assessment, they may decide to investigate formally and/or address the issue through their enforcement powers. In addition to the five areas described above, Monitor will also use other sources of information as they are made aware of during the year to consider a trust s governance rating. These include corporate governance statements, the annual governance statement, forward plans and regular governance reviews. Where they could represent governance concerns they will adjust the governance rating accordingly. Directorate of Clinical & Quality Assurance, October 2013 Page 4/5

Corporate Governance Statement Under their governance condition, NHS foundation trusts will submit a corporate governance statement within three months of the end of each financial year. The governance condition requires boards to confirm: compliance with the governance condition at the date of the statement; and forward compliance with the governance condition for the current financial year, specifying (i) any risks to compliance and (ii) any actions proposed to manage such risks. Where the corporate governance statement indicates risks to compliance with the governance condition, Monitor will consider whether any actions or other assurances are required at the time of the statement or whether it is more appropriate to maintain a watching brief. Ad hoc/triggered Reviews of Governance Should Monitor s oversight of governance indicate a material governance concern, we may request the board of the trust to carry out an immediate review into the issues behind this concern as a preliminary to or as part of a formal investigation. Where the review identifies a potential breach of the governance condition, we may investigate further and possibly take enforcement action. Financial Risk The Risk Assessment Framework also fundamentally alters the manner by which Monitor will gauge financial risk and therefore the Financial Risk Rating system previously used will no longer operate after quarter two of 2013/14. Details of the new financial risk rating system which will come into effect from quarter three have been highlighted to the Finance Committee. Directorate of Clinical & Quality Assurance, October 2013 Page 5/5